Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-194944
Filing Date
2024-08-06
Accepted
2024-08-06 16:41:41
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d879175ds3.htm S-3 375307
2 EX-4.5 d879175dex45.htm EX-4.5 303409
3 EX-4.7 d879175dex47.htm EX-4.7 97317
4 EX-4.8 d879175dex48.htm EX-4.8 96435
5 EX-4.9 d879175dex49.htm EX-4.9 88238
6 EX-5.1 d879175dex51.htm EX-5.1 16634
7 EX-5.2 d879175dex52.htm EX-5.2 21458
8 EX-23.1 d879175dex231.htm EX-23.1 1777
9 EX-FILING FEES d879175dexfilingfees.htm EX-FILING FEES 54694
10 GRAPHIC g879175g03g03.jpg GRAPHIC 38323
11 GRAPHIC g879175g60p15.jpg GRAPHIC 3452
  Complete submission text file 0001193125-24-194944.txt   1114105
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281298 | Film No.: 241180025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)